Yui Nakayama

Statistics

Publications

Citations

225

H-Index

Active since

2023

Affiliations

National Institute of Biomedical Innovation, Health and Nutrition(Current)

University of Oxford

Yui Nakayama is an author at National Institute of Biomedical Innovation, Health and Nutrition specializing in chronic kidney disease, renal pharmacology, and chronic kidney disease progression prevention.

ORCID

Publications per year

2023–2023

Publications

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Regional Difference in the Impact of COVID-19 Pandemic on Domain-Specific Physical Activity, Sedentary Behavior, Sleeping Time, and Step Count: Web-Based Cross-sectional Nationwide Survey and Accelerometer-Based Observational Study

Yosuke Yamada, Hideyuki Namba, Heiwa Date et al. · JMIR Public Health and Surveillance · 2023 · 16 citations · Full text

Public Health, Health Sciences, Population Health Sciences +17

Association between Intra- and Extra-Cellular Water Ratio Imbalance and Natriuretic Peptides in Patients Undergoing Hemodialysis

Yui Nakayama, Yosuke Yamada, Shingo Ishii et al. · Nutrients · 2023 · 11 citations · Full text

Medicine, Nephrology, Physiology +17

1–4 of 4